• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[冰岛女性对基因咨询及BRCA2基因突变检测的看法]

[Views of Icelandic women towards genetic counseling - and testing of BRCA2 mutations].

作者信息

Jonsdottir Thordis, Valdimarsdottir Heiddis, Tryggvadottir Laufey, Lund Sigrun Helga, Thordardottir Marianna, Magnusson Magnus Karl, Valdimarsdottir Unnur

机构信息

Center of Public Health sciences, Faculty of Medicine, University of Iceland.

Reykjavik University.

出版信息

Laeknabladid. 2018;104(6):289-296. doi: 10.17992/lbl.2018.06.189.

DOI:10.17992/lbl.2018.06.189
PMID:29863481
Abstract

Introduction The aim of this study was to explore the attitudes of Icelandic women towards existing genetic information, genetic counseling and genetic testing for BRCA mutations which dramatically increase risk for aggressive cancers. Materials and methods Women attending the cancer prevention clinic in Reykjavik, capital of Iceland, from October 12th until November 20th 2015 received an invitation to participate. Participation involved answering a short online questionnaire about background, family history of cancer as well as attitudes towards genetic counseling, BRCA testing and preventive use of such information. Descriptive statistics and chi-square tests were used to describe differences in attitudes towards those questions between subgroups of women. Results 1129 women (69% response rate) answered the questionnaire. Mean age was 47 years (span 21-76 years). Around half (47%) had heard fairly much about the mutations. Independent of family history of cancer, the majority of women were positive towards receiving genetic counseling (79%) and to undergo genetic testing (83%) for BRCA mutation with younger women being more interested than older women. On the other hand, only 4% of the women had already received genetic counseling and 7% undergone genetic testing. Women with family history of cancer were more knowledgeable about BRCA mutations (p<0.0001) and were less afraid of the consequence of being a mutation carrier (p<0.0001) compared to those with little or no family history. Regardless of family history, half (49%) worried that results from genetic testing could influence their health insurance. Almost all, or 97% of the women, were positive or very positive toward using existing genetic information obtained through scientific work, to inform affected indi-viduals of their mutation status. Conclusion Icelandic women are positive towards genetic counseling and testing for BRCA mutations although half of them worry that a positive result might affect their health insurance. Nevertheless, almost all women believe that existing genetic information should be used to inform carriers for preventive purposes.

摘要

引言 本研究的目的是探讨冰岛女性对现有基因信息、基因咨询以及针对BRCA突变的基因检测的态度,BRCA突变会显著增加患侵袭性癌症的风险。

材料与方法 2015年10月12日至11月20日期间,前往冰岛首都雷克雅未克癌症预防诊所就诊的女性收到了参与邀请。参与方式是回答一份简短的在线问卷,内容涉及背景、癌症家族史以及对基因咨询、BRCA检测和此类信息预防性使用的态度。描述性统计和卡方检验用于描述不同亚组女性对这些问题态度的差异。

结果 1129名女性(回复率69%)回答了问卷。平均年龄为47岁(范围21 - 76岁)。约一半(47%)的女性对这些突变了解较多。与癌症家族史无关,大多数女性对接受BRCA突变的基因咨询(79%)和进行基因检测(83%)持积极态度,年轻女性比年长女性更感兴趣。另一方面,只有4%的女性已经接受过基因咨询,7%的女性进行过基因检测。与家族史较少或无家族史的女性相比,有癌症家族史的女性对BRCA突变了解更多(p<0.0001),并且对成为突变携带者的后果担忧较少(p<0.0001)。无论家族史如何,一半(49%)的女性担心基因检测结果会影响她们的健康保险。几乎所有(97%)的女性对利用通过科学研究获得的现有基因信息告知受影响个体其突变状态持积极或非常积极的态度。

结论 冰岛女性对BRCA突变的基因咨询和检测持积极态度,尽管其中一半担心阳性结果可能影响她们的健康保险。然而,几乎所有女性都认为现有基因信息应用于告知携带者以达到预防目的。

相似文献

1
[Views of Icelandic women towards genetic counseling - and testing of BRCA2 mutations].[冰岛女性对基因咨询及BRCA2基因突变检测的看法]
Laeknabladid. 2018;104(6):289-296. doi: 10.17992/lbl.2018.06.189.
2
Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.医疗机构与美国 BRCA 基因突变风险女性讨论基因检测。
Am J Prev Med. 2018 Feb;54(2):221-228. doi: 10.1016/j.amepre.2017.10.015. Epub 2017 Dec 11.
3
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.BRCA1 和 BRCA2 基因突变携带者乳腺癌术后卵巢切除术对生存的影响。
JAMA Oncol. 2015 Jun;1(3):306-13. doi: 10.1001/jamaoncol.2015.0658.
4
Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer-an European consensus statement and expert recommendations.遗传性咨询和乳腺癌治疗决策中易感基因的检测:欧洲共识声明和专家建议。
Eur J Cancer. 2019 Jan;106:54-60. doi: 10.1016/j.ejca.2018.10.007. Epub 2018 Nov 22.
5
Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.胚系 BRCA 突变在大型基于临床的胰腺导管腺癌患者队列中的研究。
J Clin Oncol. 2015 Oct 1;33(28):3124-9. doi: 10.1200/JCO.2014.59.7401. Epub 2015 May 4.
6
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.多基因panel 检测在遗传性乳腺癌和卵巢癌风险评估中的临床可操作性。
JAMA Oncol. 2015 Oct;1(7):943-51. doi: 10.1001/jamaoncol.2015.2690.
7
BRCAPRO 6.0 Model Validation in Male Patients Presenting for BRCA Testing.BRCAPRO 6.0模型在接受BRCA检测的男性患者中的验证
Oncologist. 2015 Jun;20(6):593-7. doi: 10.1634/theoncologist.2014-0425. Epub 2015 May 6.
8
Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?以色列 BRCA1/BRCA2 突变携带者家族中表型复制型乳腺癌的发生率:非携带者的风险是否增加?
Breast Cancer Res Treat. 2012 Apr;132(2):669-73. doi: 10.1007/s10549-011-1886-3. Epub 2011 Nov 24.
9
A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.特立尼达和多巴哥乳腺癌女性及其家族的临床结构化和合作式基因检测方法。
Breast Cancer Res Treat. 2019 Apr;174(2):469-477. doi: 10.1007/s10549-018-5045-y. Epub 2018 Dec 4.
10
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation.生殖生活对有家族病史或携带BRCA突变的女性患乳腺癌风险的影响。
Oncotarget. 2017 Feb 7;8(6):9144-9154. doi: 10.18632/oncotarget.13423.